These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25200209)

  • 21. Procedure-related bleeding in elective percutaneous coronary interventions.
    Ndrepepa G; Stephan T; Fiedler KA; Guerra E; Kufner S; Kastrati A
    Eur J Clin Invest; 2015 Mar; 45(3):263-73. PubMed ID: 25645583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry.
    Vora AN; Peterson ED; McCoy LA; Garratt KN; Kutcher MA; Marso SP; Roe MT; Messenger JC; Rao SV
    JACC Cardiovasc Interv; 2016 Apr; 9(8):771-779. PubMed ID: 27101904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention.
    Liu HH; Cao YX; Jin JL; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Gao RL; Li JJ
    J Am Heart Assoc; 2021 Feb; 10(3):e018869. PubMed ID: 33506689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The experiences of myocardial infarction patients readmitted within six months of primary percutaneous coronary intervention.
    Iles-Smith H; Deaton C; Campbell M; Mercer C; McGowan L
    J Clin Nurs; 2017 Nov; 26(21-22):3511-3518. PubMed ID: 28042893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective.
    Pettersen TR; Fridlund B; Bendz B; Nordrehaug JE; Rotevatn S; Schjøtt J; Norekvål TM;
    Int J Nurs Stud; 2018 Dec; 88():16-24. PubMed ID: 30165236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
    Mehta V; Sukhija R; Mehra P; Goyal A; Yusuf J; Mahajan B; Gupta VK; Tyagi S; Palaniswamy C; Aronow WS
    Indian Heart J; 2016; 68(1):57-62. PubMed ID: 26896268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.
    Grodzinsky A; Kosiborod M; Tang F; Jones PG; McGuire DK; Spertus JA; Beltrame JF; Jang JS; Goyal A; Butala NM; Yeh RW; Arnold SV
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28904076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of periprocedural biomarker elevation on mortality in stable angina pectoris patients undergoing elective coronary intervention: a systematic review and meta-analysis including 24 666 patients.
    Soud M; Hideo-Kajita A; Ho G; Yacob O; Alahdab F; King F; Waksman R; McFadden EP; Garcia-Garcia HM
    Coron Artery Dis; 2020 Mar; 31(2):137-146. PubMed ID: 31609755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of elective--including "high risk"--percutaneous coronary interventions without on-site cardiac surgery.
    Zavala-Alarcon E; Cecena F; Ashar R; Patel R; Van Poppel S; Carlson R
    Am Heart J; 2004 Oct; 148(4):676-83. PubMed ID: 15459600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Same-Day Discharge After Elective Percutaneous Coronary Intervention in the United States With Costs and Outcomes.
    Amin AP; Pinto D; House JA; Rao SV; Spertus JA; Cohen MG; Pancholy S; Salisbury AC; Mamas MA; Frogge N; Singh J; Lasala J; Masoudi FA; Bradley SM; Wasfy JH; Maddox TM; Kulkarni H
    JAMA Cardiol; 2018 Nov; 3(11):1041-1049. PubMed ID: 30267035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Informed Decision Making for Percutaneous Coronary Intervention for Stable Coronary Disease.
    Rothberg MB; Sivalingam SK; Kleppel R; Schweiger M; Hu B; Sepucha KR
    JAMA Intern Med; 2015 Jul; 175(7):1199-206. PubMed ID: 25984988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient confidence regarding secondary lifestyle modification and knowledge of 'heart attack' symptoms following percutaneous revascularisation in Japan: a cross-sectional study.
    Kitakata H; Kohno T; Kohsaka S; Fujino J; Nakano N; Fukuoka R; Yuasa S; Maekawa Y; Fukuda K
    BMJ Open; 2018 Mar; 8(3):e019119. PubMed ID: 29549203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease.
    Rothberg MB; Sivalingam SK; Ashraf J; Visintainer P; Joelson J; Kleppel R; Vallurupalli N; Schweiger MJ
    Ann Intern Med; 2010 Sep; 153(5):307-13. PubMed ID: 20820040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
    Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
    Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease.
    Czarnecki A; Qiu F; Elbaz-Greener G; Cohen EA; Ko DT; Roifman I; Wijeysundera HC
    JACC Cardiovasc Interv; 2019 Feb; 12(3):232-241. PubMed ID: 30660456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of information presentation on beliefs about the benefits of elective percutaneous coronary intervention.
    Rothberg MB; Scherer L; Kashef MA; Coylewright M; Ting HH; Hu B; Zikmund-Fisher BJ
    JAMA Intern Med; 2014 Oct; 174(10):1623-9. PubMed ID: 25156687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study.
    Zheng X; Curtis JP; Hu S; Wang Y; Yang Y; Masoudi FA; Spertus JA; Li X; Li J; Dharmarajan K; Downing NS; Krumholz HM; Jiang L;
    JAMA Intern Med; 2016 Apr; 176(4):512-21. PubMed ID: 26974883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of left ventricular ejection fraction and medication adherence on major adverse cardiac events during the first year after successful primary percutaneous coronary interventions.
    Son YJ; Shim SK; Hwang SY; Ahn JH; Yu HY
    J Clin Nurs; 2016 Apr; 25(7-8):1101-11. PubMed ID: 26708422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program.
    Valle JA; Glorioso TJ; Bricker R; Barón AE; Armstrong EJ; Bhatt DL; Rao SV; Plomondon ME; Serruys PW; Keppetein AP; Sabik JF; Dressler O; Stone GW; Waldo SW
    JAMA Cardiol; 2019 Aug; 4(8):727-735. PubMed ID: 31241721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.